top of page

The Art & Science of
Peri- and Post-Approval Clinical Research

Renaissance Associates is a specialized Contract Research Organization (CRO) delivering elite peri- and post-approval trial execution, strategic lifecycle optimization guidance, and scientific data dissemination for the biopharmaceutical and medical device industries.

Expertise Across the Post-Approval Lifecycle

From strategic study planning through execution and scientific dissemination, Renaissance Associates provides specialized expertise to help biopharmaceutical and medical device companies maximize the clinical and commercial value of their products.

alexey-savchenko-Xe7BUe4uFBA-unsplash.jpg

Insight

Peri- & Post-Approval Strategic Guidance

Strategic clinical research designed to generate evidence that supports the continued evolution and value of commercialized products.

andrea-sonda-nw2H5tAhR4I-unsplash.jpg

Evidence

Peri- & Post-Approval Study Conduct

Expert management of post-approval clinical studies from planning through execution. Scientifically rigorous evidence-generation strategies that capitalize on the evolving regulatory environment.

samuel-castro-oq1istygZ3U-unsplash.jpg

Impact

Data Dissemination Services

Strategies that translate clinical findings into meaningful scientific communications for key audiences.

Engineered for Elite Execution

Senior-Level Expertise

Specialized teams of highly experienced clinical professionals assembled around the needs of each engagement.

Agility & Efficiency

A flexible business model designed to provide senior-level expertise without the overhead and rigidity of a traditional large CRO.

An Extension of Your Team

A highly collaborative approach built on trust, transparency, and seamless integration with internal clinical operations and medical affairs teams.

High-Touch Investigator Relationships

Experienced management of PI and KOL relationships with the professionalism, scientific rigor and regulatory discipline post-approval studies demand.

a health card and a stethoscope_edited.jpg

A Specialized Approach to Post-Approval Research

“A product’s launch is only the beginning of its commercial lifecycle story. Strategic post-approval research can generate the evidence needed to expand its value to patients, clinicians, and sponsors.”

Matt Dickason, MBA

Founder & Managing Director

Deep Experience Across Therapeutic Areas

Our teams bring specialized clinical and operational experience across a broad range of therapeutic areas, allowing us to quickly understand the scientific, regulatory, and commercial context surrounding each engagement.

Let’s Talk About What Comes Next

Whether you are planning a peri- or post-approval study, exploring opportunities to expand a product’s clinical value or looking for specialized support to execute your strategy, we would welcome the opportunity to discuss your needs.

bottom of page